Free Trial
NYSE:MED

MEDIFAST Q3 2025 Earnings Report

MEDIFAST logo
$13.94 -0.06 (-0.39%)
Closing price 03:58 PM Eastern
Extended Trading
$13.50 -0.44 (-3.16%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MEDIFAST EPS Results

Actual EPS
N/A
Consensus EPS
-$0.01
Beat/Miss
N/A
One Year Ago EPS
N/A

MEDIFAST Revenue Results

Actual Revenue
N/A
Expected Revenue
$84.10 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

MEDIFAST Announcement Details

Quarter
Q3 2025
Time
Before Market Opens
Conference Call Date
Monday, November 3, 2025
Conference Call Time
4:30PM ET

Conference Call Resources

MEDIFAST Earnings Headlines

Nvidia Times 1,000,000
Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 trillion calculations per second. Elon Musk and Nvidia’s Jensen Huang are now teaming up to deploy one million of these chips inside what could become the most advanced AI machine on the planet. But according to James Altucher, the real opportunity isn’t in Tesla or Nvidia. He’s uncovered a little-known company that Musk, Nvidia, and even 98% of the Fortune 500 already rely on to make AI 2.0 possible. Nvidia’s CEO has even called this company “essential” to their expansion.tc pixel
Why Medifast (MED) Stock Is Trading Up Today
See More MEDIFAST Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like MEDIFAST? Sign up for Earnings360's daily newsletter to receive timely earnings updates on MEDIFAST and other key companies, straight to your email.

About MEDIFAST

MEDIFAST (NYSE:MED), Inc. (NYSE: MED) is a health and wellness company specializing in clinically supported weight-loss, weight-management and healthy living products and services. Through its OPTAVIA brand, the company offers a range of meal replacement products, snacks, supplements and coaching programs designed to support metabolic health and sustainable lifestyle changes. Medifast markets its products directly to consumers via a network of independent distributors—known as OPTAVIA Coaches—who provide personalized guidance and support throughout the client’s weight‐loss journey.

Founded in 1980 by William Vitale and headquartered in Baltimore, Maryland, Medifast has grown into a nationally recognized provider of nutrition and weight‐management solutions. The company went public in 2001 and has since expanded its operations beyond the United States, serving customers in both the U.S. and Canada. Its offerings are distributed through a combination of e-commerce platforms and regional distribution centers, enabling efficient delivery of products to end users and reinforcing Medifast’s direct‐to‐consumer business model.

Under the leadership of President and Chief Executive Officer Daniel Chard, Medifast continues to invest in product innovation, digital tools and community building to strengthen customer engagement and retention. The company’s management team emphasizes evidence‐based program development and high standards of quality control, reflecting its commitment to clinical rigor and long‐term client success. With a focus on metabolic health and sustainable lifestyle transformation, Medifast aims to maintain its position as a leader in the weight‐management industry.

View MEDIFAST Profile

More Earnings Resources from MarketBeat